Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30554465 | 1.00 | DGKA (0.77) | DGKADGKZ | |
| SCHEMBL21831783 | 1.00 | DGKA (0.77) | DGKADGKZ | |
| SCHEMBL25327844 | 1.00 | DGKA (0.77) | DGKADGKZ | |
| SCHEMBL21910646 | 0.96 | DGKA (0.80) | DGKADGKZ | |
| SCHEMBL30910664 | 0.96 | DGKA (0.80) | DGKADGKZ | |
| SCHEMBL21831127 | 0.95 | DGKA (0.85) | DGKADGKZ | |
| SCHEMBL30554221 | 0.95 | DGKA (0.85) | DGKADGKZ | |
| SCHEMBL21830774 | 0.94 | DGKA (0.71) | DGKADGKZ | |
| SCHEMBL30910710 | 0.94 | DGKA (0.71) | DGKADGKZ | |
| SCHEMBL30910678 | 0.93 | DGKA (0.78) | DGKADGKZ |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112654621-B | Substituted naphthyridinone compounds useful as T cell activators | 百时美施贵宝公司 | 2024-05-14 | — | — | CN | claimed |
| EP-3814348-B9 | SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS | BRISTOL MYERS SQUIBB CO (US) | 2023-11-01 | — | — | EP | claimed |
| EP-3814348-B1 | SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS | BRISTOL MYERS SQUIBB CO (US) | 2023-08-02 | — | — | EP | claimed |
| CN-112654621-B | Substituted naphthyridinone compounds useful as T cell activators | 百时美施贵宝公司 | 2024-05-14 | — | — | CN | disclosed |
| EP-3814348-B9 | SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS | BRISTOL MYERS SQUIBB CO (US) | 2023-11-01 | — | — | EP | disclosed |
| EP-3814348-B1 | SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS | BRISTOL MYERS SQUIBB CO (US) | 2023-08-02 | — | — | EP | disclosed |